Zentalis Pharmaceuticals (ZNTL) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Zentalis Pharmaceuticals (ZNTL) over the last 4 years, with Q3 2025 value amounting to -$24.6 million.
- Zentalis Pharmaceuticals' Other Gross PP&E Adjustments fell 69.59% to -$24.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.6 million, marking a year-over-year decrease of 69.59%. This contributed to the annual value of -$30.1 million for FY2024, which is 987.74% up from last year.
- According to the latest figures from Q3 2025, Zentalis Pharmaceuticals' Other Gross PP&E Adjustments is -$24.6 million, which was down 69.59% from -$25.6 million recorded in Q2 2025.
- Zentalis Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at -$24.4 million for Q3 2024, and its period low was -$35.1 million during Q4 2022.
- In the last 4 years, Zentalis Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$27.2 million in 2023 and averaged -$28.8 million.
- Per our database at Business Quant, Zentalis Pharmaceuticals' Other Gross PP&E Adjustments surged by 1951.78% in 2023 and then crashed by 443.25% in 2025.
- Over the past 4 years, Zentalis Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$35.1 million in 2022, then grew by 5.01% to -$33.3 million in 2023, then grew by 9.88% to -$30.1 million in 2024, then increased by 18.15% to -$24.6 million in 2025.
- Its Other Gross PP&E Adjustments was -$24.6 million in Q3 2025, compared to -$25.6 million in Q2 2025 and -$26.3 million in Q1 2025.